FDECX
Price
$23.75
Change
-$0.08 (-0.34%)
Updated
Aug 15 closing price
Net Assets
5.56B
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

FDECX vs VVIAX

Header iconFDECX vs VVIAX Comparison
Open Charts FDECX vs VVIAXBanner chart's image
Fidelity Advisor Capital Development C
Price$23.75
Change-$0.08 (-0.34%)
VolumeN/A
Net Assets5.56B
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
FDECX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FDECX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDECX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. FDECX (5.56B). VVIAX pays higher dividends than FDECX: VVIAX (2.18) vs FDECX (0.11). FDECX was incepted earlier than VVIAX: FDECX (20 years) vs VVIAX (25 years). FDECX (1.68) is less costly to investors than VVIAX (0.05). FDECX is a more actively managed with annual turnover of: 16.00 vs. VVIAX (9.00). FDECX has a lower initial minimum investment than VVIAX: FDECX (0) vs VVIAX (3000). FDECX annual gain was more profitable for investors over the last year : 13.19 vs. VVIAX (7.91). FDECX return over 5 years is better than : 80.57 vs. VVIAX (68.54).
FDECXVVIAXFDECX / VVIAX
Total Expense Ratio1.680.053,360%
Annual Report Gross Expense Ratio1.680.053,360%
Fund Existence20 years25 years-
Gain YTD16.1946.517249%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.56B196B3%
Annual Yield % from dividends0.112.185%
Returns for 1 year13.197.91167%
Returns for 3 years43.5025.93168%
Returns for 5 years80.5768.54118%
Returns for 10 years78.98114.6169%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp